Open AccessColesevelam hydrochloride: A novel agent in patients with type 2 diabetes
Author(s) -
Kavita Sekhri,
Lekha Saha
Publication year - 2011
Publication title -
international journal of applied and basic medical research/international journal of applied and basic medical research
Language(s) - English
Resource type - Journals
eISSN - 2248-9606
pISSN - 2229-516X
DOI - 10.4103/2229-516x.91157
Subject(s) - hyperlipidemia , medicine , diabetes mellitus , type 2 diabetes , drug , bile acid , pharmacology , type 2 diabetes mellitus , endocrinology
Hyperglycemia and hyperlipidemia are both risk factors for the development of various complications in patients with type 2 diabetes mellitus. Colesevelam hydrochloride is a novel agent that can improve both hypercholesterolemia and hyperglycemia in such patients. It is an orally administered bile acid sequestrant with high capacity for binding bile acids. This drug can offer potential new diabetes treatment along with other drugs.